Free Trial
LON:AGR

Assura H2 2025 Earnings Report

Assura logo
GBX 47.48 +0.18 (+0.38%)
As of 10/3/2025

Assura EPS Results

Actual EPS
GBX 3.50
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Assura Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Assura Announcement Details

Quarter
H2 2025
Time
After Market Closes
Conference Call Date
Monday, July 21, 2025
Conference Call Time
3:00AM ET

Earnings Documents

Assura Earnings Headlines

This dark force is about to change everything
An unstoppable force is reshaping America — one so powerful it’s already disrupting how we work, invest, and live. Porter Stansberry calls it The Final Displacement — a rare turning point that’s only happened four times in human history, each one redefining entire eras. His new documentary reveals why this shift could trigger both immense loss and unprecedented opportunity, and what you can do to prepare before it accelerates.tc pixel
Peel Hunt Keeps Their Buy Rating on Assura plc (AGR)
See More Assura Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Assura? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Assura and other key companies, straight to your email.

About Assura

Assura (LON:AGR) is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served. We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G). Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.

View Assura Profile

More Earnings Resources from MarketBeat